| Your drug may be your problem: How and why to stop taking psychiatric medications P Breggin, D Cohen Da Capo Lifelong Books, 2007 | 268 | 2007 |
| Medications as social phenomena D Cohen, M McCubbin, J Collin, G Pérodeau Health: 5 (4), 441-469, 2001 | 258 | 2001 |
| A critique of the international consensus statement on ADHD S Timimi, J Moncrieff, J Jureidini, J Leo, D Cohen, C Whitfield, D Double, ... Clinical child and family psychology review 7 (1), 59-63, 2004 | 207 | 2004 |
| The subjective experience of taking antipsychotic medication: a content analysis of Internet data J Moncrieff, D Cohen, JP Mason Acta Psychiatrica Scandinavica 120 (2), 102-111, 2009 | 186 | 2009 |
| Do antidepressants cure or create abnormal brain states? J Moncrieff, D Cohen PLoS Medicine 3 (7), e240, 2006 | 185 | 2006 |
| Mad science: Psychiatric coercion, diagnosis, and drugs SA Kirk, G Tomi, D Cohen Routledge, 2017 | 170 | 2017 |
| Rethinking models of psychotropic drug action J Moncrieff, D Cohen Psychotherapy and psychosomatics 74 (3), 145-153, 2005 | 144 | 2005 |
| Why most biomedical findings echoed by newspapers turn out to be false: The case of attention deficit hyperactivity disorder F Gonon, JP Konsman, D Cohen, T Boraud Public Library of Science 7 (9), e44275, 2012 | 138 | 2012 |
| Broken brains or flawed studies? A critical review of ADHD neuroimaging research J Leo, D Cohen The Journal of Mind and Behavior, 29-55, 2003 | 129 | 2003 |
| Extremely unbalanced: Interest divergence and power disparties between clients and psychiatry M McCubbin, D Cohen International Journal of Law and Psychiatry 19 (1), 1-25, 1996 | 109 | 1996 |
| How do psychiatric drugs work? J Moncrieff, D Cohen Bmj 338, 2009 | 104 | 2009 |
| Clinical social work and the biomedical industrial complex T Gomory, SE Wong, D Cohen, JR Lacasse J. Soc. & Soc. Welfare 38, 135, 2011 | 99 | 2011 |
| The psychoactive effects of psychiatric medication: the elephant in the room J Moncrieff, D Cohen, S Porter Journal of psychoactive drugs 45 (5), 409-415, 2013 | 95 | 2013 |
| A critique of the use of neuroleptic drugs in psychiatry. D Cohen John Wiley & Sons, Inc., 1997 | 92 | 1997 |
| Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross … RJ S Hughes, D Cohen BMJ Open 4 (7), e005535, 2014 | 90 | 2014 |
| Factors associated with psychotropic drug use among community-dwelling older persons: A review of empirical studies P Voyer, D Cohen, S Lauzon, J Collin BMC nursing 3, 1-13, 2004 | 88 | 2004 |
| A systematic review of long-term studies of drug treated and non-drug treated depression S Hughes, D Cohen Journal of affective disorders 118 (1-3), 9-18, 2009 | 87 | 2009 |
| Civil commitment due to mental illness and dangerousness: the union of law and psychiatry within a treatment‐control system B Dallaire, M McCubbin, P Morin, D Cohen Sociology of health & illness 22 (5), 679-699, 2000 | 80 | 2000 |
| The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria P Voyer, M Préville, D Cohen, D Berbiche, SG Béland Canadian Journal on Aging/La revue canadienne du vieillissement 29 (2), 205-213, 2010 | 72 | 2010 |
| Can online consumers contribute to drug knowledge? A mixed-methods comparison of consumer-generated and professionally controlled psychotropic medication information on the … S Hughes, D Cohen Journal of medical Internet research 13 (3), e1716, 2011 | 70 | 2011 |
